Vesugen vs B7-33
| Attribute | Vesugen Khavinson vascular peptide | B7-33 Single-chain relaxin analog |
|---|---|---|
| Category | Heart & Cardiovascular Health | Heart & Cardiovascular Health |
| Best known for | Vascular endothelium bioregulator research | Anti-fibrotic and cardiovascular research |
| In plain English | The 'blood vessel' member of the Russian bioregulator family. | It mimics relaxin's anti-scarring effects without the full hormone's downsides. |
| How it works | Proposed to modulate gene expression in endothelial cells, supporting vascular tone and reducing aging-related dysfunction. | Selectively activates the RXFP1 receptor's anti-fibrotic signaling pathway while avoiding cAMP-mediated effects. |
| Researchers study | Atherosclerosis, hypertension, and vascular aging. | Cardiac fibrosis, pulmonary fibrosis, and tissue-remodeling models. |
| Internet discussion | Discussed alongside Cardiogen and Epitalon in cardiovascular longevity stacks. | Niche; discussed in anti-aging and cardiovascular research circles. |
Vesugen
Vascular endothelium bioregulator research
The 'blood vessel' member of the Russian bioregulator family.
Proposed to modulate gene expression in endothelial cells, supporting vascular tone and reducing aging-related dysfunction.
Atherosclerosis, hypertension, and vascular aging.
Discussed alongside Cardiogen and Epitalon in cardiovascular longevity stacks.
Vesugen is a Khavinson vascular bioregulator researched for endothelial and cardiovascular support.
B7-33
Anti-fibrotic and cardiovascular research
It mimics relaxin's anti-scarring effects without the full hormone's downsides.
Selectively activates the RXFP1 receptor's anti-fibrotic signaling pathway while avoiding cAMP-mediated effects.
Cardiac fibrosis, pulmonary fibrosis, and tissue-remodeling models.
Niche; discussed in anti-aging and cardiovascular research circles.
B7-33 is a single-chain relaxin analog researched for anti-fibrotic and cardiovascular protection.